KG Blume
Impact in
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Oncology top 5%
- CAR-T cell therapy research
Papers in
- Hematology 35
- Hematopoietic Stem Cell Transplantation 28
- Acute Myeloid Leukemia Research 9
- Chronic Myeloid Leukemia Treatments 6
- Genetics 12
- Chronic Lymphocytic Leukemia Research 6
KG Blume
55 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Hematology 1.1k
- Oncology 818
- Immunology 631
- Genetics 241
- Public Health, Environmental and Occupational Health 424
Countries citing papers authored by KG Blume
This map shows the geographic impact of KG Blume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KG Blume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KG Blume more than expected).
Fields of papers citing papers by KG Blume
This network shows the impact of papers produced by KG Blume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KG Blume. The network helps show where KG Blume may publish in the future.
Co-authors
The 25 scholars most cited alongside KG Blume, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 1 | |
| 2 | LOW DOSE TBI CONDITIONING FOR HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) FROM HLA-MATCHED RELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: INFLUENCE OF FLUDARABINE OR CYTOREDUCTIVE AUTOGRAFTS ON OUTCOME | 2002 | 11 |
| 3 | 1997 | 58 | |
| 4 | 1995 | 66 | |
| 5 | 1994 | 57 | |
| 6 | Bone marrow transplantation for thalassemia. The USA experience. | 1994 | 20 |
| 7 | A general overview of the status of bone marrow transplantation for hematologic diseases. | 1993 | 3 |
| 8 | 1992 | 10 | |
| 9 | 1991 | 47 | |
| 10 | Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. Hit paper breakdown → | 1991 | 518 |
| 11 | 1991 | 71 | |
| 12 | Assessment of purging with multidrug resistance (MDR) modulators and VP-16: results of long-term marrow culture. | 1990 | 12 |
| 13 | 1987 | 6 | |
| 14 | A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone. | 1987 | 64 |
| 15 | 1985 | 4 | |
| 16 | 1983 | 7 | |
| 17 | 1983 | 54 | |
| 18 | 1983 | 5 | |
| 19 | 1980 | 19 | |
| 20 | 1977 | 4 |
About KG Blume
KG Blume is a scholar working on Hematology, Genetics, Oncology, Transplantation and Pediatrics, Perinatology and Child Health, having authored 56 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (28 papers), Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (8 papers), Erythrocyte Function and Pathophysiology (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Polyomavirus and related diseases (6 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Hematology (1.1k citations), Oncology (818 citations), Immunology (631 citations), Genetics (241 citations) and Public Health, Environmental and Occupational Health (424 citations). KG Blume has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include RS Negrin, I G Schmidt-Wolf, Hans‐Peter Kiem, I L Weissman, MR O’Donnell, RS Negrin, SJ Forman, JL Fahey, NJ Chao and SJ Forman. Their work appears in journals such as Blood, Journal of Clinical Oncology, The Journal of Infectious Diseases, Annals of Hematology and Transfusion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.